SCHM:NYE-Schwab U.S. Mid-Cap ETF (USD)

ETF | Mid-Cap Blend |

Last Closing

USD 82.51

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.21M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Mid-Cap Blend

Symbol Name Price(Change) Market Cap
IJH iShares Core S&P Mid-Cap ETF

+0.05 (+0.08%)

USD 91.24B
IWR iShares Russell Mid-Cap ETF

+0.03 (+0.03%)

USD 36.18B
MDY SPDR® S&P MIDCAP 400 ETF Trus..

+0.48 (+0.08%)

USD 23.21B
VXF Vanguard Extended Market Index..

+0.15 (+0.08%)

USD 20.35B
SPMD SPDR Russell Small Cap Complet..

+0.04 (+0.07%)

USD 11.24B
XMHQ Invesco S&P MidCap Quality ETF

+0.08 (+0.08%)

USD 5.69B
JHMM John Hancock Multifactor Mid C..

-0.07 (-0.12%)

USD 4.01B
IVOO Vanguard S&P Mid-Cap 400 Index..

+0.10 (+0.10%)

USD 2.25B
EQAL Invesco Russell 1000 Equal Wei..

-0.03 (-0.06%)

USD 0.62B
FSMD Fidelity Small-Mid Factor

-0.05 (-0.12%)

USD 0.49B

ETFs Containing SCHM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.55% 17% F 55% F
Dividend Return 1.11% 71% C- 22% F
Total Return 10.65% 17% F 49% F
Trailing 12 Months  
Capital Gain 24.81% 11% F 62% D
Dividend Return 1.78% 78% C+ 25% F
Total Return 26.58% 5% F 58% F
Trailing 5 Years  
Capital Gain 48.00% 5% F 69% C-
Dividend Return 8.27% 72% C 26% F
Total Return 56.27% 5% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.76% N/A N/A 69% C-
Dividend Return 12.18% N/A N/A 67% D+
Total Return 1.42% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 22.65% N/A N/A 46% F
Risk Adjusted Return 53.75% N/A N/A 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike